Related Experiment Video
Updated: Jun 11, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Callosal tissue loss in multiple system atrophy--a one-year follow-up study
Martina Minnerop1, Eileen Lüders, Karsten Specht
1Institute of Neurosciences and Medicine-1, Research Centre Jülich, Jülich, Germany. m.minnerop@fz-juelich.de
Summary
Multiple system atrophy (MSA) causes brain tissue loss, particularly white matter in the cerebellum and brainstem. Progressive degeneration affects the corpus callosum, correlating with motor function decline in MSA patients.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Multiple system atrophy (MSA) is a rare, fatal neurodegenerative disorder.
- It affects multiple brain regions including the basal ganglia, cerebellum, and cerebral cortex.
- Clinical variants include cerebellar (MSA-C) and parkinsonian (MSA-P).
Purpose of the Study:
- To investigate gray and white matter differences in MSA patients compared to controls.
- To analyze longitudinal changes in brain tissue over one year.
- To identify specific patterns of neurodegeneration in MSA.
Main Methods:
- Voxel-based morphometry (VBM) was used to analyze brain scans.
- 14 MSA patients and 14 matched controls were studied.
- Baseline and 1-year follow-up scans were compared.
Main Results:
- MSA patients showed reduced gray matter in the cerebellum and cortex, and white matter in the brainstem and cerebellar peduncles at baseline.
- Progressive white matter loss was observed along the middle cerebellar peduncles (ponto-cerebellar tract) in MSA patients.
- Additional white matter reduction in the corpus callosum was detected at follow-up, linked to motor impairments.
Conclusions:
- The ponto-cerebellar tract degeneration is a prominent feature of MSA.
- Corpus callosum atrophy may represent a disease-specific pattern in MSA.
- These findings correlate with the motor deficits observed in MSA patients.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

